StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.5
Power Rank trend -> Rising
03/27/2025 16:10:00 EST
McKesson Corporation (MCK)
Industry: Medical Distribution
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, MCK has been trading in a range between $666.36 and $620.16 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
MCK is trading below resistance at $666.36, about 0% to the upside. There is support at $607.52 -9% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
McKesson Corporation $MCK entered a Green zone 23 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $650.48, a potential down side of -1.89% from the recent price of 663.02. The stock is trading 1.17% (potential upside) below its 52 week high of $670.79 and 43.08 % (potential downside) above its 52 week low of $463.38 - based on the recent price.
Company Summary
McKesson Corporation provides healthcare services in the United States and internationally It operates through four segments: U. S.
News
| McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025 I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs and geopolitical tensions ensures stability, making it a reliable investment amid economic uncertainties. The company's GLP-1 and oncology franchises are key growth drivers, with GLP-1 revenue growing 45% year-over-year and oncology patient visits increasing steadily. Source: Seeking Alpha Tue, 25 Mar 2025 01:13:18 -0400 Sentiment: Neutral |
| McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note McKesson (MCK) closed at $660.86 in the latest trading session, marking a -0.05% move from the prior day. Source: Zacks Investment Research Mon, 24 Mar 2025 18:55:36 -0400 Sentiment: Neutral |
| Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves. Source: CNBC Television Mon, 24 Mar 2025 13:12:59 -0400 Sentiment: Neutral |
| McKesson (MCK) and Visa (V) Are 2 Dividend Growth Stocks to Buy For a Lifetime of Passive Income Investing in dividend growth stocks is a smart, reliable way to build passive income that lasts a lifetime, and it's worth considering if you're eyeing financial freedom. Source: 24/7 Wall Street Sat, 22 Mar 2025 10:57:37 -0400 Sentiment: Positive |
| McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know In the latest trading session, McKesson (MCK) closed at $663.79, marking a +0.33% move from the previous day. Source: Zacks Investment Research Wed, 19 Mar 2025 19:01:28 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 670.7899 52 Week Low: 463.376 Beta: 0.512 50 Day MA: 621.8724 200 Day MA: 577.8895 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0.572 Qtr Revenue Growth YOY: 0.178 Forward PE: 18.1488 Trailing PE: 30.3959